With the stock market surging, investors are looking at more speculative opportunities for outsized gains. But investors should be careful with low-priced equities, and in particular these three overvalued penny stocks. The allure of grabbing a multi-bagger penny stock is understandable. But traders should avoid these particular high P/E penny stocks. It’s easy to point
0 Comments
The biotech sector will always house stocks with explosive upside potential. The very nature of the sector ensures that will continue to be the case. Developing breakthrough pharmaceuticals and medical devices requires massive sums of money and long periods of time.  Firms in the space must clear significant hurdles, including FDA regulatory requirements that often
0 Comments
The electric-vehicle revolution and the evolution towards self-driving are two of the more exciting technological changes in our lifetime. The proliferation of EVs has not only enabled start-up automakers with enormous potential to be formed and begin selling tens of thousands of vehicles, but EVs have sped up the digitalization of automobiles. As a result,
0 Comments
Finding overvalued stocks to sell isn’t hard. Investors today have more information than ever, promoting company transparency. However, this also means investors must contextualize this information when investing. Often, a couple of negative headlines don’t alter a company’s investment thesis. Savvy investors know there are many reasons to sell a stock, but emotion should rarely
0 Comments
No investment can be called 100% safe. However, JPMorgan Chase (NYSE:JPM) stock isn’t likely to bankrupt its long-term investors anytime soon. The stock gets a “B” rating as JPMorgan Chase continues to widen its influence through merger and acquisition activity. Don’t get the wrong message here. The “B” rating means that JPMorgan Chase isn’t infallible, especially
0 Comments